Finished
TAP Block With Liposomal Bupivacaine Versus Bupivacaine in Robotic Hysterectomy
NCT02289079 · University of Minnesota · Updated 10 May 2023
- What is being tested
- Bupivacaine; liposomal bupivacaine
- For
- Acute Pain
- Kind of study
- Tests a treatment or device on volunteers. Phase 4.
- Who can join
- Ages 18 years and older. About 60 people. The full rules are on the registry page.
- Where
- Not stated
- When
- Starts or started June 2013, ends Oct 2014. Registered 13 Nov 2014.
- Results
- Posted on the registry on 18 Jan 2016.
In the researchers' words
The purpose of the study is to compare pain control after robotic hysterectomy surgery using either liposomal bupivacaine or Bupivacaine when injected during a transversus abdominis plane (TAP) block. Robotic hysterectomy is when a patient is electively having robotic assisted removal of one's uterus. Both medications liposomal bupivacaine and Bupivacaine are standard of care in these types of surgeries.